Brittany Bychkovsky

Assistant Professor of Medicine

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Brittany Bychkovsky is an Assistant Professor of Medicine at the Dana-Farber Cancer Institute in the United States. Her research focuses on cancer predisposition, particularly the implications of low allele frequency variants and germline multi-gene panel testing. She has contributed to several recent articles examining the significance of pathogenic variants in breast cancer and the role of CHEK2 variants in cancer phenotypes and clinical care.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Deborah L. McGuinness

Rensselaer Polytechnic Institute

UNITED STATES

View details

Lan Coffman

Assistant Professor

University of Pittsburgh

UNITED STATES

View details

Judy Garber

Chief, Division of Cancer Genetics and Prevention

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brittany Bychkovsky

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception

Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis

Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis

Call for action: expanding global access to hereditary cancer genetic testing

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2

Differences in Cancer Phenotypes Among Frequent <i>CHEK2</i> Variants and Implications for Clinical Care—Checking <i>CHEK2</i>

Call for action: expanding global access to hereditary cancer genetic testing.

Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program.

Collaborators (3)

Deborah L. McGuinness

Lan Coffman

Judy Garber

Make your next move.